Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A Asset Resilience Ratio
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A asset resilience ratio. Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (688212) has an Asset Resilience Ratio of 6.09% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 688212 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (2021–2024)
Asset resilience ratio of Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A from 2021 to 2024. This chart shows how Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's Asset Resilience Ratio has changed over time. Read Shanghai Aohua Photoelectricity Endoscop (688212) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Shanghai Aohua Photoelectricity Endoscop total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥113.00 Million | 6.09% |
| Total Liquid Assets | CN¥113.00 Million | 6.09% |
Asset Resilience Insights
- Limited Liquidity: Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A maintains only 6.09% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085 |
Medical Devices | 7.69% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A Asset Resilience Ratio by Year (2021–2024)
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A asset resilience ratio by year from 2021 to 2024. The table below shows the annual Asset Resilience Ratio data for Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 7.25% | CN¥126.81 Million ≈ $18.56 Million |
CN¥1.75 Billion ≈ $255.89 Million |
-13.66pp |
| 2023-12-31 | 20.91% | CN¥333.60 Million ≈ $48.82 Million |
CN¥1.60 Billion ≈ $233.41 Million |
-9.45pp |
| 2022-12-31 | 30.37% | CN¥443.40 Million ≈ $64.88 Million |
CN¥1.46 Billion ≈ $213.66 Million |
+26.96pp |
| 2021-12-31 | 3.41% | CN¥46.03 Million ≈ $6.74 Million |
CN¥1.35 Billion ≈ $197.44 Million |
-- |
About Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
Shanghai Aohua Photoelectricity Endoscope Co., Ltd. engages in the research and development, manufacture, and sale of electronic endoscope equipment and endoscopic diagnosis and treatment consumables in China and internationally. It offers electronic digestive endoscopes, otolaryngoscopes, bronchoscopes, and endoscopic diagnostic and treatment consumables for use in respiratory medicine, general … Read more